{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:26:23Z","timestamp":1786983983017,"version":"build-2736575974"},"reference-count":74,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T00:00:00Z","timestamp":1703635200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ad.2023.12.001","type":"journal-article","created":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T11:40:37Z","timestamp":1703763637000},"page":"433-448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Topical and Intralesional Therapies for Hidradenitis Suppurativa: A Systematic Literature Review"],"prefix":"10.1016","volume":"115","author":[{"given":"J.C.","family":"Pascual","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Hern\u00e1ndez-Quiles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"S\u00e1nchez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Viudez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Belinch\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Sivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2023.12.001_bib0375","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMcp1014163","article-title":"Clinical practice. Hidradenitis suppurativa","volume":"366","author":"Jemec","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ad.2023.12.001_bib0380","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1468-3083.2009.03356.x","article-title":"Hidradenitis suppurativa","volume":"23","author":"Revuz","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2023.12.001_bib0385","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","article-title":"Prevalence and factors associated with hidradenitis suppurativa: results from two case\u2013control studies","volume":"59","author":"Revuz","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.12.001_bib0390","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/bjd.13090","article-title":"Risk factors, clinical course and long-term prognosis in hidradenitis suppurativa: a cross-sectional study","volume":"171","author":"Kromann","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2023.12.001_bib0395","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2133.2009.09430.x","article-title":"Hidradenitis suppurativa and inflammatory bowel disease: are they associated? Results of a pilot study","volume":"162","author":"Van der Zee","year":"2010","journal-title":"Br J Dermatol"},{"issue":"Pt 1","key":"10.1016\/j.ad.2023.12.001_bib0400","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0190-9622(96)90321-7","article-title":"The prevalence of hidradenitis suppurativa and its potential precursor lesions","volume":"35","author":"Jemec","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.12.001_bib0405","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jaad.2011.10.024","article-title":"Profound disturbances of sexual health in patients with acne inversa","volume":"67","author":"Kurek","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.12.001_bib0410","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/jdv.12966","article-title":"European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa","volume":"29","author":"Zouboulis","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2023.12.001_bib0415","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/jdv.12567","article-title":"Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa","volume":"29","author":"Shavit","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2023.12.001_bib0420","first-page":"CD010081","article-title":"Interventions for hidradenitis suppurativa","author":"Ingram","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ad.2023.12.001_bib0425","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jaad.2019.02.068","article-title":"North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations. Part II. Topical, intralesional, and systemic medical management","volume":"81","author":"Alikhan","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.12.001_bib0430","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/jdv.15233","article-title":"Hidradenitis suppurativa\/acne inversa: a practical framework for treatment optimization \u2013 systematic review and recommendations from the HS ALLIANCE working group","volume":"33","author":"Zouboulis","year":"2019","journal-title":"J Eur Acad Dermatol"},{"key":"10.1016\/j.ad.2023.12.001_bib0435","doi-asserted-by":"crossref","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"29","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ad.2023.12.001_bib0440","unstructured":"https:\/\/www.crd.york.ac.uk\/PROSPEROFILES\/361114_PROTOCOL_20220918.pdf [accessed 02.05.23]."},{"key":"10.1016\/j.ad.2023.12.001_bib0445","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000431175","article-title":"Hidradenitis suppurativa\/acne inversa: criteria for diagnosis, severity assessment, classification and disease evaluation","volume":"231","author":"Zouboulis","year":"2015","journal-title":"Dermatology"},{"key":"10.1016\/j.ad.2023.12.001_bib0450","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/bjd.16672","article-title":"A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process","volume":"179","author":"Thorlacius","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2023.12.001_bib0455","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ad.2023.12.001_bib0460","series-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analyses","author":"Wells","year":"2000"},{"key":"10.1016\/j.ad.2023.12.001_bib0465","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1039\/c6pp00082g","article-title":"Photodynamic therapy with intralesional methylene blue and a 635nm light-emitting diode lamp in hidradenitis suppurativa: a retrospective follow-up study in 7 patients and a review of the literature","volume":"15","author":"Agut-Busquet","year":"2016","journal-title":"Photochem Photobiol Sci"},{"key":"10.1016\/j.ad.2023.12.001_bib0470","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/phpp.12709","article-title":"Ultrasound-guided photodynamic therapy with intralesional methylene blue and a 635nm light-emitting diode lamp in hidradenitis suppurativa: a retrospective study of 41 patients","volume":"38","author":"Gamissans","year":"2022","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.ad.2023.12.001_bib0475","doi-asserted-by":"crossref","first-page":"102339","DOI":"10.1016\/j.pdpdt.2021.102339","article-title":"Intralesional photodynamic therapy in hidradenitis suppurativa: getting closer to the target","volume":"34","author":"Garcias-Ladaria","year":"2021","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"10.1016\/j.ad.2023.12.001_bib0480","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jdermsci.2016.12.014","article-title":"Treatment of hidradenitis suppurativa with intralesional photodynamic therapy with 5-aminolevulinic acid and 630nm laser beam","volume":"85","author":"Suarez-Valladares","year":"2017","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.ad.2023.12.001_bib0485","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/bjd.13385","article-title":"Treatment of hidradenitis suppurativa with intralesional photodynamic therapy using a laser diode attached to an optical cable: a promising new approach","volume":"172","author":"Valladares-Narganes","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2023.12.001_bib0490","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/ced.12459","article-title":"New topical photodynamic therapy for treatment of hidradenitis suppurativa using methylene blue niosomal gel: a single-blind, randomized, comparative study","volume":"40","author":"Fadel","year":"2015","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ad.2023.12.001_bib0495","first-page":"614","article-title":"Effectiveness of 5-aminolevulinic acid photodynamic therapy in the treatment of hidradenitis suppurativa: a report of 5 cases","volume":"105","author":"Andino-Navarrete","year":"2014","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2023.12.001_bib0500","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1111\/j.1365-2230.2008.03094.x","article-title":"Treatment of recalcitrant hidradenitis suppurativa with photodynamic therapy: report of five cases","volume":"34","author":"Sotiriou","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ad.2023.12.001_bib0505","first-page":"381","article-title":"Treatment of hidradenitis suppurativa by photodynamic therapy with aminolevulinic acid: preliminary results","volume":"10","author":"Schweiger","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.ad.2023.12.001_bib0510","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1039\/c2pp25124h","article-title":"A retrospective analysis of real-life practice of off-label photodynamic therapy using methyl aminolevulinate (MAL-PDT) in 20 Italian dermatology departments. Part 1. Inflammatory and aesthetic indications","volume":"12","author":"Calzavara-Pinton","year":"2013","journal-title":"Photochem Photobiol Sci"},{"key":"10.1016\/j.ad.2023.12.001_bib0515","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/DSS.0000000000002112","article-title":"Intralesional triamcinolone may not be beneficial for treating acute hidradenitis suppurativa lesions: a double-blind, randomized, placebo-controlled trial","volume":"46","author":"Fajgenbaum","year":"2020","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ad.2023.12.001_bib0520","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1038\/s41598-020-70176-x","article-title":"Ultrasound-assisted intralesional corticosteroid infiltrations for patients with hidradenitis suppurativa","volume":"10","author":"Salvador-Rodr\u00edguez","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ad.2023.12.001_bib0525","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000499934","article-title":"Intralesional triamcinolone for fistulous tracts in hidradenitis suppurativa: an uncontrolled prospective trial with clinical and ultrasonographic follow-up","volume":"236","author":"Alvarez","year":"2020","journal-title":"Dermatology"},{"key":"10.1016\/j.ad.2023.12.001_bib0530","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1080\/09546634.2019.1655524","article-title":"Intralesional corticosteroid injection for the treatment of hidradenitis suppurativa: a multicenter retrospective clinical study","volume":"32","author":"Garcia-Martinez","year":"2021","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.ad.2023.12.001_bib0535","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/ijd.15124","article-title":"Efficacy of high-dose intralesional triamcinolone for hidradenitis suppurativa","volume":"60","author":"Garelik","year":"2021","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ad.2023.12.001_bib0540","doi-asserted-by":"crossref","first-page":"e15068","DOI":"10.1111\/dth.15068","article-title":"Ultrasound-guided injection of intralesional steroids in acute hidradenitis suppurativa lesions: a prospective study","volume":"34","author":"Iannone","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2023.12.001_bib0545","doi-asserted-by":"crossref","first-page":"e15710","DOI":"10.1111\/dth.15710","article-title":"Intralesional steroid injections to target sinus tract fibrosis in hidradenitis suppurativa: results from an ultrasound-based retrospective study","volume":"35","author":"Sechi","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2023.12.001_bib0550","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jaad.2016.06.049","article-title":"Intralesional triamcinolone for flares of hidradenitis suppurativa (HS): a case series","volume":"75","author":"Riis","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.12.001_bib0555","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000515450","article-title":"Topical 15% resorcinol is associated with high treatment satisfaction in patients with mild to moderate hidradenitis suppurativa","volume":"238","author":"Docampo-Sim\u00f3n","year":"2022","journal-title":"Dermatology"},{"key":"10.1016\/j.ad.2023.12.001_bib0560","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2230.2009.03377.x","article-title":"Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa","volume":"35","author":"Boer","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ad.2023.12.001_bib0565","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/1346-8138.16275","article-title":"Effectiveness and safety of topical 15% resorcinol in the management of mild-to-moderate hidradenitis suppurativa: a cohort study","volume":"49","author":"Cordero-Ramos","year":"2022","journal-title":"J Dermatol"},{"key":"10.1016\/j.ad.2023.12.001_bib0570","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/bjd.19337","article-title":"Efficacy and safety of topical resorcinol 15% as long-term treatment of mild-to-moderate hidradenitis suppurativa: a valid alternative to clindamycin in the panorama of antibiotic resistance","volume":"183","author":"Molinelli","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2023.12.001_bib0575","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jaad.2017.07.008","article-title":"Topical 15% resorcinol for hidradenitis suppurativa: an uncontrolled prospective trial with clinical and ultrasonographic follow-up","volume":"77","author":"Pascual","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.12.001_bib0580","doi-asserted-by":"crossref","first-page":"e15439","DOI":"10.1111\/dth.15439","article-title":"Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild-to-moderate hidradenitis suppurativa: a retrospective study","volume":"35","author":"Molinelli","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2023.12.001_bib0585","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-4362.1983.tb02150.x","article-title":"Topical treatment of hidradenitis suppurativa with clindamycin","volume":"22","author":"Clemmensen","year":"1983","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ad.2023.12.001_bib0590","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0190-9622(98)70272-5","article-title":"Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa","volume":"39","author":"Jemec","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.12.001_bib0595","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s40257-020-00537-9","article-title":"Botulinum toxin type B for hidradenitis suppurativa: a randomised, double-blind, placebo-controlled pilot study","volume":"21","author":"Grimstad","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ad.2023.12.001_bib0600","doi-asserted-by":"crossref","first-page":"e13901","DOI":"10.1111\/dth.13901","article-title":"Intralesional ultrasound-guided combined treatment with triamcinolone plus lincomycin in hidradenitis suppurativa: a pilot study","volume":"33","author":"Fania","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2023.12.001_bib0605","doi-asserted-by":"crossref","first-page":"e13868","DOI":"10.1111\/dth.13868","article-title":"Efficacy of topical ichthammol 10% for hidradenitis suppurativa: case series and systematic review of its use in dermatology","volume":"33","author":"Fisher","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2023.12.001_bib0610","doi-asserted-by":"crossref","first-page":"e12599","DOI":"10.1111\/dth.12599","article-title":"Efficacy and tolerability of a lotion containing triethyl citrate, ethyl linoleate, and GT peptide-10 in the adjuvant treatment of hidradenitis suppurativa: real-life data","volume":"31","author":"Skroza","year":"2018","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2023.12.001_bib0615","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1097\/DSS.0000000000003510","article-title":"An open-label, prospective, pilot study of hypertonic saline for hidradenitis suppurativa","volume":"48","author":"Porter","year":"2022","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ad.2023.12.001_bib0620","doi-asserted-by":"crossref","first-page":"e12841","DOI":"10.1111\/dth.12841","article-title":"Two cases of hidradenitis suppurativa and botulinum toxin type a therapy: a novel approach for a pathology that is still difficult to manage","volume":"32","author":"Campanati","year":"2019","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2023.12.001_bib0625","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/09546630902882063","article-title":"Pulsed dye laser-mediated photodynamic therapy for acne inversa is not successful: a pilot study on four cases","volume":"20","author":"Passeron","year":"2009","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.ad.2023.12.001_bib0630","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jaad.2012.11.030","article-title":"Efficacy of intralesional photodynamic therapy for the treatment of hidradenitis suppurativa","volume":"68","author":"Rodr\u00edguez-Prieto","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.12.001_bib0635","doi-asserted-by":"crossref","first-page":"102891","DOI":"10.1016\/j.pdpdt.2022.102891","article-title":"ALA-iPDT for follicular occlusion tetrad concomitant with pachyonychia congenital type II and ankylosing spondylitis","volume":"39","author":"Yan","year":"2022","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"10.1016\/j.ad.2023.12.001_bib0640","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-2133.2010.10193.x","article-title":"Bath psoralen plus ultraviolet A for hidradenitis suppurativa: a review of 13 patients","volume":"164","author":"Shareef","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2023.12.001_bib0645","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1365-2133.2005.06475.x","article-title":"Photodynamic therapy using aminolaevulinic acid does not lead to clinical improvement in hidradenitis suppurativa","volume":"152","author":"Strauss","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2023.12.001_bib0650","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1142\/S1793545816400022","article-title":"Topical 5-aminolevulinic acid photodynamic therapy improved refractory acne conglobata and perifolliculitis capitis abscedens et suffodiens rather than hidradenitis suppurativa","volume":"9","author":"Zhang","year":"2016","journal-title":"J Innov Opt Health Sci"},{"key":"10.1016\/j.ad.2023.12.001_bib0655","doi-asserted-by":"crossref","first-page":"e15708","DOI":"10.1111\/dth.15708","article-title":"Management of scarring HS fistulas with intralesional steroids","volume":"35","author":"Iannone","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2023.12.001_bib0660","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1080\/09546634.2021.1906842","article-title":"Intralesional corticosteroid injections are less painful without local anesthetic: a double-blind, randomized controlled trial","volume":"33","author":"Zakria","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.ad.2023.12.001_bib0665","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/ddg.13045","article-title":"New magistral formulation for the topical treatment of suppurative hidradenitis with clindamycin-containing solution according to the S1-guideline recommendation","volume":"14","author":"Mrowietz","year":"2016","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.ad.2023.12.001_bib0670","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/09546634.2019.1638878","article-title":"Crystallized phenol for sacral hidradenitis suppurativa","volume":"32","author":"Turan","year":"2021","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.ad.2023.12.001_bib0675","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jdermsci.2016.08.010","article-title":"Combination of oral zinc gluconate and topical triclosan: an anti-inflammatory treatment modality for initial hidradenitis suppurativa","volume":"84","author":"Hessam","year":"2016","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.ad.2023.12.001_bib0680","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.anplas.2017.03.012","article-title":"Non-surgical treatments for hidradenitis suppurativa: a systematic review","volume":"62","author":"Robert","year":"2017","journal-title":"Ann Chir Plast Esthet"},{"key":"10.1016\/j.ad.2023.12.001_bib0685","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ad.2019.04.008","article-title":"Systematic review of light-based treatments for hidradenitis suppurativa","volume":"111","author":"Gracia Caza\u00f1a","year":"2020","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2023.12.001_bib0690","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1159\/000524121","article-title":"Intralesional treatments in hidradenitis suppurativa: a systematic review","volume":"238","author":"Cuenca-Barrales","year":"2022","journal-title":"Dermatology"},{"key":"10.1016\/j.ad.2023.12.001_bib0695","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/00042728-200802000-00012","article-title":"Surgical treatment of hidradenitis suppurativa with gentamicin sulfate: a prospective randomized study","volume":"34","author":"Buimer","year":"2008","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.ad.2023.12.001_bib0700","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/bjd.16093","article-title":"Towards global consensus on core outcomes for hidradenitis suppurativa research: an update from the HISTORIC consensus meetings I and II","volume":"178","author":"Thorlacius","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2023.12.001_bib0705","first-page":"548","article-title":"A method for achieving consensus on rheumatoid arthritis outcome measures: the OMERACT conference process","volume":"20","author":"Fried","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ad.2023.12.001_bib0710","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1046\/j.1468-3083.2000.00087.x","article-title":"The natural history of hidradenitis suppurativa","volume":"14","author":"Von Der Werth","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2023.12.001_bib0715","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa1504370","article-title":"Two phase 3 trials of adalimumab for hidradenitis suppurativa","volume":"375","author":"Kimball","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ad.2023.12.001_bib0720","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jaad.2018.06.046","article-title":"Apremilast for moderate hidradenitis suppurativa: results of a randomized controlled trial","volume":"80","author":"Vossen","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.12.001_bib0725","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(23)00022-3","article-title":"Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials","volume":"401","author":"Kimball","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ad.2023.12.001_bib0730","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/jamadermatol.2015.3903","article-title":"Safety and efficacy of anakinra in severe hidradenitis suppurativa: a randomized clinical trial","volume":"152","author":"Tzanetakou","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ad.2023.12.001_bib0735","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/bjd.17928","article-title":"Even mild hidradenitis suppurativa impairs quality of life","volume":"181","author":"Senthilnathan","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2023.12.001_bib0740","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/bjd.17537","article-title":"British Association of Dermatologists guidelines for the management of hidradenitis suppurativa (acne inversa) 2018","volume":"180","author":"Ingram","year":"2019","journal-title":"Br J Dermatol"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731023010062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731023010062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T09:41:04Z","timestamp":1714556464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731023010062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":74,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0001731023010062"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2023.12.001","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical and Intralesional Therapies for Hidradenitis Suppurativa: A Systematic Literature Review","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2023.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 AEDV. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}